Skip to content

Fascial Tissue Response to Manual Therapy: Implications in Long COVID-19

Fascial Tissue Response to Manual Therapy: Implications in Long COVID-19

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06348186
Enrollment
30
Registered
2024-04-04
Start date
2024-02-01
Completion date
2025-08-31
Last updated
2024-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

Long COVID, Manual Therapy, Fascia, Rehabilitation

Brief summary

According to the World Health Organization (WHO), as of mid-September 2022, more than 21 million Brazilians have recovered from COVID-19. However, post-infection symptoms continue to appear months after the end of the acute infection, a syndrome called long COVID. Therefore, the aim of this study is to investigate the responses of fascia-focused manual therapy in participants with long COVID.

Detailed description

Participants reported to have long COVID, of both sexes, aged between 20 and 80 years, from the community, outpatient clinics and hospitals will be evaluated. The treatment of participants will be carried out at the CEFID-UDESC Physiotherapy School Clinic, where they will undergo assessment of the biomechanical and viscoelastic properties of tissues, postural control, pain and quality of life. For normality analysis, the Shapiro-Wilk test will be applied, and according to the distribution of the data, parametric or non-parametric tests will be used. Pre- and post-assessment and treatment data will be compared using descriptive statistics and Student's t-test with a significance level of p=0.05 for parametric data or Wilcoxon for non-parametric data.

Interventions

OTHERGuidebook

Folder that will be given to the participant to carry out 5 minutes of intervention daily

OTHERGuidebook and Myofascial Reorganization® (RMF).

The intervention will be carried out once a week for 30 minutes for 6 weeks. It will include passive, active-assisted moments (with and without load). In addition to a folder that will be given to the participant to carry out 5 minutes of intervention daily.

Sponsors

Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina
CollaboratorUNKNOWN
University of the State of Santa Catarina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Participants are randomly assigned to one of two or groups, typically an intervention group (fascia-focused manual therapy) and a control group. Participants are randomly allocated. Participants and outcomes assessor are blinded.

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants diagnosed with long COVID, of both sexes, aged between 20 and 80 years, from the community, outpatient clinics and hospitals.

Exclusion criteria

* Participants with suspected deep vein thrombosis; Participants with neurological disorders.

Design outcomes

Primary

MeasureTime frameDescription
Functioning and disability6 weeksWill be assessed using the World Health Organization Disability Assessment questionnaire (WHO-DAS 2.0), translated and validated for the Brazilian population by Silveira et al. (2013).
Biomechanical and tissue viscoelastic properties6 weeksWill be evaluated by MyotonPro (MytonPro, Myoton Ltd.s., Tartu, Estonia)

Secondary

MeasureTime frameDescription
Work capacity6 weeksWill be assessed by the Work Limitations Questionnaire, WLQ-25 translated and validated for the Brazilian population by Soárez et al (2007).
Level of Quality of life6 weeksWill be assessed by the World Health Organization Questionnaire in its short version, validated in the Brazilian population and by the Medical Outcomes Study 36-Item Short Form Health questionnaire Survey validated for Brazilian-Portuguese.
Upper limb dysfunctions6 weeksWill be assessed using the Arm, Shoulder and Hand Dysfunctions questionnaire (DASH), translated and validated for the Brazilian population by Orfale et al (2005).
Balance6 weeksWill be assessed using the Neurocom Balance Platform (VRS Sport) and its NeuroCom®Balance Manager program (Neurocom International, Inc, Clackamas, OR).

Countries

Brazil

Contacts

Primary ContactLarissa Sinhorim
larissasinhorim@hotmail.com47984057340

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026